Literature DB >> 18511124

Adaptive properties and heterogeneity of dopamine D(2) receptors - pharmacological implications.

Arvid Carlsson1, Maria L Carlsson.   

Abstract

In this review, we focus on the marked adaptability of dopamine D(2) receptors to varying agonist levels and we discuss the extent to which this phenomenon can account for the heterogeneity of these receptors in regard to function and pharmacological responsiveness. We emphasize the significance of a distinction between synaptic and extrasynaptic receptors in this context. For example, the application of this dichotomy appears to shed new light on the various subgroups of antipsychotic drugs and the mechanisms underlying their different profiles.

Mesh:

Substances:

Year:  2007        PMID: 18511124     DOI: 10.1016/j.brainresrev.2007.09.007

Source DB:  PubMed          Journal:  Brain Res Rev        ISSN: 0165-0173


  8 in total

Review 1.  The 'atypicality' of antipsychotics: a concept re-examined and re-defined.

Authors:  Gerhard Gründer; Hanns Hippius; Arvid Carlsson
Journal:  Nat Rev Drug Discov       Date:  2009-02-13       Impact factor: 84.694

2.  Glial cell line-derived neurotrophic factor receptor alpha 2 (GFRA2) gene is associated with tardive dyskinesia.

Authors:  Renan P Souza; Vincenzo de Luca; Gary Remington; Jeffrey A Lieberman; Herbert Y Meltzer; James L Kennedy; Albert H C Wong
Journal:  Psychopharmacology (Berl)       Date:  2010-04-06       Impact factor: 4.530

Review 3.  Drug-induced parkinsonism in the elderly: incidence, management and prevention.

Authors:  José Luis López-Sendón; María Angeles Mena; Justo García de Yébenes
Journal:  Drugs Aging       Date:  2012-02-01       Impact factor: 3.923

4.  Reversal of prolonged dopamine inhibition of dopaminergic neurons of the ventral tegmental area.

Authors:  Sudarat Nimitvilai; Mark S Brodie
Journal:  J Pharmacol Exp Ther       Date:  2010-02-17       Impact factor: 4.030

5.  Effects of metoclopramide on the mouse anterior pituitary during the estrous cycle.

Authors:  Regina Célia Teixeira Gomes; Carina Verna; Ricardo S Simões; Roberta B Wolff; Edmund C Baracat; José Maria Soares
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

Review 6.  Integrated signaling in heterodimers and receptor mosaics of different types of GPCRs of the forebrain: relevance for schizophrenia.

Authors:  Kjell Fuxe; Daniel Marcellino; Amina S Woods; Leo Giuseppina; Tiziana Antonelli; Luca Ferraro; Sergio Tanganelli; Luigi F Agnati
Journal:  J Neural Transm (Vienna)       Date:  2009-01-21       Impact factor: 3.575

Review 7.  The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue.

Authors:  Ralf Brisch; Arthur Saniotis; Rainer Wolf; Hendrik Bielau; Hans-Gert Bernstein; Johann Steiner; Bernhard Bogerts; Katharina Braun; Anna Katharina Braun; Zbigniew Jankowski; Jaliya Kumaratilake; Jaliya Kumaritlake; Maciej Henneberg; Tomasz Gos
Journal:  Front Psychiatry       Date:  2014-05-19       Impact factor: 4.157

Review 8.  Abnormal striatal dopamine transmission in schizophrenia.

Authors:  Jerome Brunelin; Shirley Fecteau; Marie-Françoise Suaud-Chagny
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.